Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
Clinical trial NCT05383183 · UNKNOWN
Trial details
- NCT number
- NCT05383183
- Sponsor
- Daewoong Bio Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2025-06-30
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.